BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37916188)

  • 1. Role of aggressive locoregional surgery in treatment strategies for ipsilateral supraclavicular lymph node metastasis of breast cancer: a real-world cohort study.
    Feng K; Xing Z; Dai Q; Cheng H; Wang X
    Front Mol Biosci; 2023; 10():1248410. PubMed ID: 37916188
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of surgery on locoregional treatment of patients with breast cancer newly diagnosed with ipsilateral supraclavicular lymph node metastasis.
    Liu BW; Chen LX; Ma K; Chi JR; Yang ZJ; Yu Y; Cao XC
    J Cancer Res Ther; 2022 Apr; 18(2):496-502. PubMed ID: 35645120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: A multicenter retrospective study.
    Song YC; Kong J; Li N; Liu XL; Li XH; Zhu LY; Wang YW; Fang H; Jing H; Tang Y; Li YX; Wang XH; Zhang J; Wang SL
    Radiother Oncol; 2023 Jun; 183():109639. PubMed ID: 36990395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Role of Supraclavicular lymph node dissection in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis].
    Zhang W; Qi XM; Chen AX; Zhang P; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):374-379. PubMed ID: 28535656
    [No Abstract]   [Full Text] [Related]  

  • 5. Cervical Lymph Node Involvement above the Supraclavicular Fossa in Breast Cancer: Comparison with Stage IIIC (KROG 18-02).
    Kim JS; Kim K; Shin KH; Kim JH; Ahn SD; Kim SS; Kim YB; Chang JS; Choi DH; Park W; Kim TH; Chun M; Cha J; Kim JH; Lee DS; Lee SY; Park HJ
    J Breast Cancer; 2020 Apr; 23(2):194-204. PubMed ID: 32395378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraclavicular lymph node dissection with radiotherapy versus radiotherapy alone for operable breast cancer with synchronous ipsilateral supraclavicular lymph node metastases: a real-world cohort study.
    Ai X; Wang M; Li J; Hu Y; Hou L; Zheng X; Yan Y; Pan Q; Jin Y; Liu W; Tan X; Tian Y; Zhang Y; Tang P; Jiang J
    Gland Surg; 2020 Apr; 9(2):329-341. PubMed ID: 32420257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.
    Wernicke AG; Goodman RL; Turner BC; Komarnicky LT; Curran WJ; Christos PJ; Khan I; Vandris K; Parashar B; Nori D; Chao KS
    Breast Cancer Res Treat; 2011 Feb; 125(3):893-902. PubMed ID: 20853176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
    Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
    Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR).
    Lv M; Li J; Guo H; Wang C; Tian P; Ma Y; Chen X; Luo S
    Ann Surg Oncol; 2021 Sep; 28(9):5098-5109. PubMed ID: 33598861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
    Giuliano AE; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Hunt KK; Morrow M; Ballman K
    Ann Surg; 2010 Sep; 252(3):426-32; discussion 432-3. PubMed ID: 20739842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement.
    Diao K; Andring LM; Barcenas CH; Singh P; Carisa Le-Petross H; Reed VK; Reddy JP; Bloom ES; Ahmad NR; Mayo LL; Perkins GH; Mitchell MP; Nead KT; Tereffe W; Smith BD; Woodward WA
    Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):66-74. PubMed ID: 34710521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
    Lyu MH; Ma YZ; Tian PQ; Guo HH; Wang C; Liu ZZ; Chen XC
    Chin Med J (Engl); 2021 Nov; 134(22):2692-2699. PubMed ID: 34743149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of different local treatments in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis.
    Chang XZ; Yin J; Sun J; Zhang XH; Cao XC
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S158-61. PubMed ID: 24516053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14).
    Kim K; Kim SS; Shin KH; Kim JH; Ahn SD; Choi DH; Park W; Lee SY; Chun M; Kim JH; Kim YB; Cha J; Park HJ; Lee DS; Jung W
    Clin Breast Cancer; 2020 Feb; 20(1):51-60. PubMed ID: 31629642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of radiotherapy in breast cancer patients with isolated ipsilateral supraclavicular lymph node metastasis without distant metastases at diagnosis: a retrospective analysis of Chinese patients.
    Wu SG; Sun JY; Zhou J; Li FY; Lin Q; Lin HX; He ZY
    Onco Targets Ther; 2014; 7():281-8. PubMed ID: 24627640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between surgery plus radiotherapy and radiotherapy alone in treating breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
    Sun XF; Wang YJ; Huang T; Niu LJ; Zhang Q; Liu ZZ
    Gland Surg; 2020 Oct; 9(5):1513-1520. PubMed ID: 33224826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of extracapsular extension of axillary lymph node metastases in breast cancer.
    Ilknur GB; Hilmi A; Tülay C; Oguz C; Selma S; Serdar S; Uğur Y; Pinar B; Omer H; Münir K;
    Tumori; 2004; 90(1):107-11. PubMed ID: 15143982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
    Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
    [No Abstract]   [Full Text] [Related]  

  • 20. The significance of systematic lymph node dissection in surgery for early-stage non-small cell lung cancer patients aged ≤40 years.
    Guo ZY; Ren JH; Xu YY; Liu RJ; Tao H; Huang J; Tan Q
    J Thorac Dis; 2021 Feb; 13(2):1196-1204. PubMed ID: 33717592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.